Biotech Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Arthroscopy

CONMED Corporation Announces Third Quarter 2007 Financial Results

Net income, on a GAAP basis, for the third quarter increased 151% to $8.4 million, or $0.29 per diluted share, compared to third quarter 2006 GAAP net income of $3.3 million, or $0.12 per diluted share. For comparative purposes, the September 2007 GAAP net income increased 33% over the non-GAAP net income in the third quarter of 2006 of $6.3 million or $0.22 per diluted share. The adjusted, non-GAAP figures for the third quarter 2006 exclude acquisition-transition costs, facility closure charges and product termination costs (see attached reconciliation for additional...

• View Other Issues of Biotech Law Weekly
  
• View Other NewsRx Publications